Literature DB >> 15367624

Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.

Feng Feng1, Adam Davis, Julie-Anne Lake, Jill Carr, Wei Xia, Christopher Burrell, Peng Li.   

Abstract

Virion infectivity factor (Vif) protein of human immunodeficiency virus type 1 (HIV-1) is essential for the productive infection of primary human CD4 T lymphocytes and macrophages. Vif overcomes the HIV-inhibitory effects of cellular factor APOBEC3G, which has cytidine deaminase activity. We previously reported the isolation of a Vif-interacting ring finger protein, Triad 3, from a human leukocyte cDNA library, using the yeast two-hybrid system. The full-length cellular protein homologue of Triad 3 has been recently identified as the zinc finger protein inhibiting NF-kappaB (ZIN). Sequence analysis indicates that Triad 3 protein contains all four major ring-like motifs of ZIN. We report here that ZIN binds to purified Vif in vitro and that Triad 3/ZIN interacts with HIV-1 Vif in transfected human 293T cells, as demonstrated by coimmunoprecipitation. To test the biological relevance of this interaction, we produced infectious HIV-1 NL4.3 in the presence or absence of cotransfected ZIN. HIV-1 NL4.3 virus stocks produced in the presence of exogenously expressed ZIN were twofold less infectious in a single-cycle infectivity assay than virus produced in the absence of exogenous ZIN. It was further shown that cells infected with HIV NL4.3 virus stocks produced in the presence of exogenously expressed ZIN were impaired in viral DNA synthesis by twofold. The impairment in viral reverse transcription and the reduction in single-cycle viral infectivity were both shown to be dependent on the presence of Vif in the virus producer cells. The possible mechanisms by which ZIN interferes with the early events of HIV-1 replication are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367624      PMCID: PMC516435          DOI: 10.1128/JVI.78.19.10574-10581.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.

Authors:  J H Simon; M H Malim
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Role of Vif in human immunodeficiency virus type 1 reverse transcription.

Authors:  J Goncalves; Y Korin; J Zack; D Gabuzda
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.

Authors:  J Goncalves; B Shi; X Yang; D Gabuzda
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Role of vif during packing of the core of HIV-1.

Authors:  S Höglund; A Ohagen; K Lawrence; D Gabuzda
Journal:  Virology       Date:  1994-06       Impact factor: 3.616

5.  Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle.

Authors:  D Blanc; C Patience; T F Schulz; R Weiss; B Spire
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

6.  Subcellular localization of the Vif protein of human immunodeficiency virus type 1.

Authors:  J Goncalves; P Jallepalli; D H Gabuzda
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.

Authors:  P Sova; D J Volsky
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.

Authors:  Mohammad A Khan; Hirofumi Akari; Sandra Kao; Claudia Aberham; David Davis; Alicia Buckler-White; Klaus Strebel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.

Authors:  M Courcoul; C Patience; F Rey; D Blanc; A Harmache; J Sire; R Vigne; B Spire
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.

Authors:  H Liu; X Wu; M Newman; G M Shaw; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  5 in total

1.  Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.

Authors:  Bindong Liu; Phuong Thi Nguyen Sarkis; Kun Luo; Yunkai Yu; Xiao-Fang Yu
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.

Authors:  Atuhani Burnett; Paul Spearman
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

Review 3.  The ring between ring fingers (RBR) protein family.

Authors:  Birgit Eisenhaber; Nina Chumak; Frank Eisenhaber; Marie-Theres Hauser
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

4.  The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.

Authors:  James H Miller; Vlad Presnyak; Harold C Smith
Journal:  Retrovirology       Date:  2007-11-24       Impact factor: 4.602

Review 5.  RBR E3 ubiquitin ligases: new structures, new insights, new questions.

Authors:  Donald E Spratt; Helen Walden; Gary S Shaw
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.